Trase has secured a $107 million seed funding round led by ARCH Venture Partners, with participation from Red Cell Partners. The capital injection targets the development of Trase Origin, an agentic operating system designed to run full-stack autonomous artificial intelligence networks across heavily regulated industries. Operating with 55 team members between Seattle and Washington, D.C., the enterprise startup plans to use the capital to scale its commercial go-to-market teams.
The software architecture addresses rigid compliance and data sovereignty requirements in high-stakes fields. Trase deploys governance layers, auditability trails, and reinforcement learning loops to handle complex workflows safely. Commenting on the operational transition, CEO Grant Verstandig stated that "agents are handling the onerous, immutable tasks that bog down highly trained individuals."
A live implementation within the Division of Cardiology at Duke University Health System indicates significant administrative overhead reductions. The system deployed a specialized agent to automatically sort and route more than 5,000 monthly incoming patient faxes, a process previously managed manually by licensed nurses and medical assistants. Early observations indicate that the autonomous routing software executes data triage 7.1 times faster than traditional manual processing.
The clinical automation saved Duke Health staffers 1,395 hours per month, unlocking an estimated $285,450 in annual personnel capacity without requiring headcount reductions. Manesh Patel, MD, Chief of the Division of Cardiology at Duke Health, noted that when the system was initialized, "it processed the lion's share of them by the end of the day."
